Follow us

Leading international law firm Herbert Smith Freehills has advised China International Capital Corporation (CICC) as the sole sponsor of Neusoft Xikang Holdings Inc. (09686.HK)'s listing on the Main Board of the Hong Kong Stock Exchange today.

全球领先的律师事务所史密夫斐尔于东软熙康控股有限公司(09686.HK)在香港联交所主板上市的项目中担任独家保荐人中金公司的律师并提供法律服务。

Neusoft Xikang developed China’s first city-specific cloud hospital platform, and has since expanded its network to connects local governments, medical institutions, patients and insurers to enable equitable access to medical resources and more effective and efficient delivery of healthcare. As of 31 March 2023, the company has the largest cloud hospital network in China in terms of the number of cities covered, according to Frost & Sullivan.

"We congratulate Neusoft Xikang, one of China's leading digital healthcare providers, on its listing on the Hong Kong Stock Exchange," said China Managing Partner Matt Emsley. "We are delighted to have worked with the company and its sole sponsor on this IPO and wish them continued success."

Herbert Smith Freehills leads the legal market in advising sponsors and underwriters on Hong Kong IPOs. In the past two years, the firm has advised on 17 successful listings in Hong Kong, ranking third among 65 international and local law firms in Hong Kong, according to Ryanben Capital.

"This is just the latest medical service company that we have advised on a Hong Kong listing in recent years," said Hong Kong senior registered foreign lawyer Stanley Xie. "From traditional industries to innovative sectors, we look forward to continuing our support to clients for their fundraising activities."

Partners Matt Emsley, Stanley Xie (Senior Registered Foreign Lawyer) and Jin Kong (Senior Registered Foreign Lawyer) jointly led a cross-office team advising the sole sponsor, assisted by Agatha Shen (International Partner), Sean Ji (Counsel), Christina Wang (Associate) and Katherine Chen (Legal Assistant) from the Joint Operation with Kewei in Shanghai, Brian Ge (Senior Associate) and Bryan Zhu (Associate) from Beijing, Echo Shen (Senior Associate), Kaiwen Sun (Associate), Bryan Cheung (Associate), Hilary Chong (Legal Manager) and Emily Wan (Paralegal) from Hong Kong.

Legal manager Marine Jin led Herbert Smith Freehills Kewei Joint Operation’s Alternative Legal Services business to provide high-efficiency solutions for verification and other document-intensive processes during the listing, assisted by legal analysts Chunqin Li and Jarros Fang.

根据弗若斯特沙利文的资料,东软熙康打造了中国首个以城市为入口的云医院平台,并建立了一个云医院网络,将地方政府、医疗机构、患者及保险公司联系起来,以实现公平地获取医疗资源并更有效及高效地交付医疗机构。截至2023年3月31日,按覆盖的城市数量计算,东软熙康是中国最大的云医院网络。

史密夫斐尔中国管理合伙人艾迈修(Matt Emsley)表示:“东软熙康是中国领先的数字医疗服务提供商,祝贺公司在联交所上市。我们非常荣幸在这次IPO中与东软熙康和保荐人合作,衷心祝愿他们不断取得成功。”

史密夫斐尔在为保荐人和承销商就香港IPO上市提供法律服务方面处于市场领先地位。根据瑞恩资本(Ryanben Capital)的数据,本所在过去两年里为17家公司在香港上市提供法律服务,在香港65家国际和本土律所中名列第三。

科伟史密夫斐尔联营办公室合伙人(高级注册外国律师)谢守德(Stanley Xie)表示:“这是史密夫斐尔近年服务的又一家医疗服务领域公司上市。史密夫斐尔在资本市场的专长覆盖了从传统到创新的广泛领域,期待继续为客户的融资活动提供支持。”

合伙人艾迈修、谢守德和孔瑾率领三地办公室的律师团队为此次上市的独家保荐人提供法律服务。主要团队成员包括:上海联营办公室沈雪琦(International Partner)、季晓源(Counsel)、汪永芳(Associate)和陈旖珏(Legal Assistant);北京办公室葛轶(Senior Associate)和朱步凡(Associate) ;以及香港办公室沈黄贇(Senior Associate)、孙凯文(Associate)、张皓阳(Associate)、种欢子(Legal Manager)和Emily Wan (Paralegal)。

金燊(Legal Manager)率领的科伟史密夫斐尔联营办公室替代性法律服务(ALT)联合团队在上市项目期间为招股书验证及其他文件密集型工作提供高效率的解决方案。李纯沁(Legal Analyst)和方夹心(Legal Analyst)提供支持。

Key contacts

Matthew Emsley photo

Matthew Emsley

Partner, Hong Kong

Matthew Emsley
Stanley Xie photo

Stanley Xie

Chief Representative, Head of Beijing, Mainland China

Stanley Xie
Jin Kong photo

Jin Kong

Senior Foreign Registered Lawyer (USA – New York), Hong Kong

Jin Kong

Media contact

For further information on this article please contact

Sally Greig

Head of Communications, Asia

Hong Kong

Media contact

For further information on this article please contact

Vivian Huang

Communications Manager, China

Beijing

Stay in the know

We’ll send you the latest insights and briefings tailored to your needs

Mainland China Hong Kong Corporate Equity Capital Markets Capital Markets Pharmaceuticals and Healthcare Healthcare Matthew Emsley Stanley Xie Jin Kong